The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority responsible for reviewing drugs, biologics, and medical devices and monitoring safety after approval.
PMDA requirements influence global development programs when studies include Japanese sites or are used to support Japanese marketing applications. Sponsors must align with PMDA expectations for clinical evidence, safety reporting, and quality documentation. PMDA engagement often involves detailed consultations on trial design, endpoints, and data standards. Strong alignment supports efficient multinational submissions and consistent regulatory strategy.